Literature DB >> 19344048

The opioid-exposed newborn: assessment and pharmacologic management.

Lauren M Jansson1, Martha Velez, Cheryl Harrow.   

Abstract

The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344048      PMCID: PMC2729086     

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  30 in total

1.  Neonatal abstinence syndrome: assessment and management.

Authors:  L P Finnegan; J F Connaughton; R E Kron; J P Emich
Journal:  Addict Dis       Date:  1975

2.  Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs.

Authors: 
Journal:  Pediatrics       Date:  1998-06       Impact factor: 7.124

Review 3.  Current management of the neonatal abstinence syndrome: a critical analysis of the evidence.

Authors:  J G Theis; P Selby; Y Ikizler; G Koren
Journal:  Biol Neonate       Date:  1997

Review 4.  Medical complications in methadone patients.

Authors:  M J Kreek
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

5.  Pregnancy and addiction. A comprehensive care model.

Authors:  L M Jansson; D Svikis; J Lee; P Paluzzi; P Rutigliano; F Hackerman
Journal:  J Subst Abuse Treat       Date:  1996 Jul-Aug

6.  Diminished illicit drug use as a consequence of long-term methadone maintenance.

Authors:  E Gottheil; R C Sterling; S P Weinstein
Journal:  J Addict Dis       Date:  1993

7.  Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Authors:  Johan Kakko; Markus Heilig; Ihsan Sarman
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

8.  Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.

Authors:  Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Pediatrics       Date:  2008-08-11       Impact factor: 7.124

9.  Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.

Authors:  Lauren M Jansson; Janet A Dipietro; Andrea Elko; Martha Velez
Journal:  J Matern Fetal Neonatal Med       Date:  2007-09

10.  The Opioid dependent mother and newborn dyad: non-pharmacologic care.

Authors:  Martha Velez; Lauren M Jansson
Journal:  J Addict Med       Date:  2008-09       Impact factor: 3.702

View more
  63 in total

1.  Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.

Authors:  Walter K Kraft; Kevin Dysart; Jay S Greenspan; Eric Gibson; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Addiction       Date:  2010-10-06       Impact factor: 6.526

2.  Oral squamous cell carcinoma in a pigtailed macaque (Macaca nemestrina).

Authors:  Diane E Stockinger; Derek L Fong; Keith W Vogel; W McIntyre Durning; Anne E Torrence; Timothy M Rose; Jeannette P Staheli; Audrey Baldessari; Robert D Murnane; Renee R Hukkannen
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

3.  Is periconceptional opioid use safe?

Authors:  Felix Chan; Gideon Koren
Journal:  Can Fam Physician       Date:  2015-05       Impact factor: 3.275

Review 4.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

5.  Sex differences in prescription opioid use patterns assessed through a community engagement program in Florida.

Authors:  Mirsada Serdarevic; Catherine W Striley; Kelly K Gurka; Robert F Leeman; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2019-09-20       Impact factor: 4.492

Review 6.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

7.  Maternal buprenorphine treatment and infant outcome.

Authors:  Lauren M Jansson; Martha L Velez; Krystle McConnell; Nancy Spencer; Michelle Tuten; Hendree Jones; Rebeca Rios; Van L King; Neeraj Gandotra; Lorraine Millio; Janet A DiPietro
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

Review 8.  Evaluation and management of opioid dependence in pregnancy.

Authors:  Eliza M Park; Samantha Meltzer-Brody; Joji Suzuki
Journal:  Psychosomatics       Date:  2012-08-14       Impact factor: 2.386

9.  Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome.

Authors:  Elisha M Wachman; Marie J Hayes; Barry M Lester; Norma Terrin; Mark S Brown; David A Nielsen; Jonathan M Davis
Journal:  J Pediatr       Date:  2014-07-01       Impact factor: 4.406

10.  Prenatal methadone exposure and neonatal neurobehavioral functioning.

Authors:  Martha L Velez; Lauren M Jansson; Jennifer Schroeder; Erica Williams
Journal:  Pediatr Res       Date:  2009-12       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.